• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?].

作者信息

Cosset J-M, Deutsch É, Bazire L, Mazeron J-J, Chargari C

机构信息

Centre de radiothérapie Charlebourg, groupe Amethyst, 65, avenue Foch, 92250 La Garenne-Colombes, France.

Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94600 Villejuif, France; Inserm, U1030 radiothérapie moléculaire et innovations thérapeutiques, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Université Paris-Saclay, 114, rue Édouard-Vaillant, 94805 Villejuif, France.

出版信息

Cancer Radiother. 2020 Jun;24(3):179-181. doi: 10.1016/j.canrad.2020.04.003. Epub 2020 May 1.

DOI:10.1016/j.canrad.2020.04.003
PMID:32389579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252150/
Abstract
摘要

相似文献

1
[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?].[低剂量肺部放疗治疗 COVID-19 相关细胞因子风暴综合征：为何不呢？]
Cancer Radiother. 2020 Jun;24(3):179-181. doi: 10.1016/j.canrad.2020.04.003. Epub 2020 May 1.
2
Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure.研究低剂量胸部放疗作为治疗新冠肺炎患者以预防呼吸衰竭的方法。
Radiat Res. 2020 Jul 8;194(1):1-8. doi: 10.1667/RADE-20-00108.1.
3
Low dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence?低剂量放射治疗新冠病毒肺炎：有支持性证据吗？
Int J Radiat Biol. 2020 Oct;96(10):1224-1227. doi: 10.1080/09553002.2020.1762020. Epub 2020 May 6.
4
Radiotherapy in the fight against pneumonia associated with SARS-CoV-2.抗击新型冠状病毒肺炎的放射治疗
Int J Radiat Biol. 2020 Nov;96(11):1319-1322. doi: 10.1080/09553002.2020.1822560. Epub 2020 Sep 24.
5
Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China.中国武汉 COVID-19 疫情期间接受放射治疗的癌症患者的结局。
JAMA Oncol. 2020 Sep 1;6(9):1457-1459. doi: 10.1001/jamaoncol.2020.2783.
6
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗？
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
7
The Impact of the Acute Phase of COVID-19 on Radiotherapy Demand in South East Wales.新冠疫情急性期对威尔士东南部放疗需求的影响
Clin Oncol (R Coll Radiol). 2020 Oct;32(10):e217. doi: 10.1016/j.clon.2020.05.013. Epub 2020 May 27.
8
Can Transdermal Photobiomodulation Help Us at the Time of COVID-19?在新冠疫情期间，经皮光生物调节疗法能帮助我们吗？
Photobiomodul Photomed Laser Surg. 2020 May;38(5):258-259. doi: 10.1089/photob.2020.4870. Epub 2020 Apr 24.
9
Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum.冠状病毒疫情与重症监护中的体外治疗：欲求和平，先备战。
Blood Purif. 2020;49(3):255-258. doi: 10.1159/000507039. Epub 2020 Mar 13.
10
Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.肺部在细胞因子风暴眼中的神经支配：神经免疫相互作用与 COVID-19。
Nat Rev Neurol. 2020 Nov;16(11):645-652. doi: 10.1038/s41582-020-0402-y. Epub 2020 Aug 25.

引用本文的文献

1
Population Studies and Molecular Mechanisms of Human Radioadaptive Capabilities: Is It Time to Rethink Radiation Safety Standards?人类辐射适应性能力的人群研究与分子机制：是时候重新审视辐射安全标准了吗？
Int J Mol Sci. 2024 Dec 18;25(24):13543. doi: 10.3390/ijms252413543.
2
COVID-19-Associated Pneumonia: Radiobiological Insights.新型冠状病毒肺炎相关肺炎：放射生物学见解
Front Pharmacol. 2021 May 25;12:640040. doi: 10.3389/fphar.2021.640040. eCollection 2021.
3
[Low dose radiotherapy for COVID-19 pneumopathy: Biological rationale and literature review].[低剂量放疗治疗新型冠状病毒肺炎肺病变：生物学原理及文献综述]
Cancer Radiother. 2021 Jul;25(5):494-501. doi: 10.1016/j.canrad.2021.03.005. Epub 2021 Apr 9.
4
Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia.低剂量辐射可增加病毒感染和肺炎期间肺巨噬细胞的免疫抑制特性。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1283-1294. doi: 10.1016/j.ijrobp.2021.03.022. Epub 2021 Mar 13.
5
Diagnostic, Prognostic, and Therapeutic Use of Radiopharmaceuticals in the Context of SARS-CoV-2.放射性药物在新型冠状病毒肺炎背景下的诊断、预后评估及治疗应用
ACS Pharmacol Transl Sci. 2021 Jan 15;4(1):1-7. doi: 10.1021/acsptsci.0c00186. eCollection 2021 Feb 12.
6
Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders.低剂量电离辐射作为一种赫美汀：与年龄相关疾病的实验观察和治疗前景。
Biogerontology. 2021 Apr;22(2):145-164. doi: 10.1007/s10522-020-09908-5. Epub 2021 Jan 9.
7
Immunopathogenesis and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的免疫发病机制与治疗。
Theranostics. 2021 Jan 1;11(1):316-329. doi: 10.7150/thno.49713. eCollection 2021.
8
The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.抗癌治疗对合并 COVID-19 的癌症患者的影响：系统评价和荟萃分析。
Cancer Med. 2021 Feb;10(3):1043-1056. doi: 10.1002/cam4.3692. Epub 2020 Dec 31.
9
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients.低剂量放射疗法与恢复期血浆：一种混合方法如何使新冠肺炎患者的益处最大化。
J Biomed Phys Eng. 2020 Aug 1;10(4):387-394. doi: 10.31661/jbpe.v0i0.2006-1125. eCollection 2020 Aug.
10
COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations.新冠病毒（COVID-19）：引入低剂量辐射作为治疗肺炎的有效方法，该方法不应引发选择压力和新的突变。
J Biomed Phys Eng. 2020 Jun 1;10(3):247-250. doi: 10.31661/jbpe.v0i0.2005-1114. eCollection 2020 Jun.

本文引用的文献

1
Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?低剂量放射治疗是否是新冠病毒肺炎的一种潜在治疗方法？
Radiother Oncol. 2020 Jun;147:221. doi: 10.1016/j.radonc.2020.04.004. Epub 2020 Apr 6.
2
How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.新冠病毒是如何致人死亡的？不确定性正阻碍医生选择治疗方法的能力。
Nature. 2020 Apr;580(7803):311-312. doi: 10.1038/d41586-020-01056-7.
3
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19：单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
4
Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.意大利北部严重急性呼吸综合征冠状病毒2疫情期间炎症性肠病患者的平稳病程
Gastroenterology. 2020 Jul;159(1):371-372. doi: 10.1053/j.gastro.2020.03.062. Epub 2020 Apr 2.
5
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.一系列接受免疫抑制靶向治疗的慢性关节炎患者的 COVID-19 临床病程。
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
6
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?新冠病毒感染中针对过度炎症反应的免疫抑制：一把双刃剑？
Lancet. 2020 Apr 4;395(10230):1111. doi: 10.1016/S0140-6736(20)30691-7. Epub 2020 Mar 24.
7
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.关于新型冠状病毒肺炎和使用免疫检查点抑制剂进行抗癌治疗的争议。
Immunotherapy. 2020 Apr;12(5):269-273. doi: 10.2217/imt-2020-0067. Epub 2020 Mar 26.
8
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.冠状病毒与免疫抑制患者：第三次疫情期间的实际情况
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.
9
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
10
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.肾移植受者长期免疫抑制后 COVID-19 肺炎的成功康复。
Am J Transplant. 2020 Jul;20(7):1859-1863. doi: 10.1111/ajt.15869. Epub 2020 Mar 31.